New Psoriasis Biologics Achieve Promising Phase-II Results - Skin and Allergy News Digital Network

Skin and hypersensitivity reaction News Digital Network brand-new Psoriasis Biologics Achieve Promising Phase-II Results Skin and Allergy News Digital system LISBON – Validation of the interleukin-17 cytokine house in psoriasis pathophysiology has gotten a boost from positive, phase II clinical trials involving two new biologic agents. The double-blind, placebo-controlled, phase II studies documented ... New disease of the skin Drug Looks Promising in Trials eMaxHealth all ii news articles » Link To Article